Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accounts Payables: 2017-2021

Historic Accounts Payables for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $4.3 million.

  • Cogent Biosciences' Accounts Payables rose 580.59% to $4.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.3 million, marking a year-over-year increase of 580.59%. This contributed to the annual value of $732,000 for FY2020, which is 77.00% down from last year.
  • Cogent Biosciences' Accounts Payables amounted to $4.3 million in Q3 2021, which was up 118.32% from $2.0 million recorded in Q2 2021.
  • Cogent Biosciences' 5-year Accounts Payables high stood at $5.5 million for Q3 2018, and its period low was $315,000 during Q1 2021.
  • For the 3-year period, Cogent Biosciences' Accounts Payables averaged around $1.6 million, with its median value being $1.6 million (2019).
  • Per our database at Business Quant, Cogent Biosciences' Accounts Payables plummeted by 77.00% in 2020 and then skyrocketed by 580.59% in 2021.
  • Over the past 5 years, Cogent Biosciences' Accounts Payables (Quarterly) stood at $1.3 million in 2017, then rose by 12.85% to $1.5 million in 2018, then surged by 109.55% to $3.2 million in 2019, then plummeted by 77.00% to $732,000 in 2020, then soared by 580.59% to $4.3 million in 2021.
  • Its last three reported values are $4.3 million in Q3 2021, $2.0 million for Q2 2021, and $315,000 during Q1 2021.